Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset 21-10-2024, 11:00

TMC Announces Corporate Update on Expected Timeline, Application Costs and Production Capacity Following Part II of the 28th Session of the International Seabed Authority 2-08-2023, 03:39

GlucoTonic Reviews (EXPOSED): Is This Natural Formula a Real Diabetes Breakthrough or Just Clever Hype? 7-04-2025, 19:45